During the past decade, Premier Vision conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 5 clinical trials were completed, i.e. on average, 166.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Premier Vision" are "Myopia" (2 trials), "Visual Acuity" (2 trials) and "Refractive Error" (1 trials). Many other conditions were trialed in "Premier Vision" in a lesser frequency.

Most popular intervention types in "Premier Vision" are "Device" (5 trials). Other intervention types were less common.

The name of intervention was led by "9618X investigational lipid eye drops" (1 trials), "Blink® Tears" (1 trials), "Investigational Contact Lens" (1 trials), "Marketed Contact Lens" (1 trials) and "comfilcon A" (1 trials). Other intervention names were less common.

The vast majority of trials in "Premier Vision" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Premier Vision". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Premier Vision, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Premier Vision, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".